| __timestamp | Gilead Sciences, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 24890000000 | 91813000 |
| Thursday, January 1, 2015 | 32639000000 | 178203000 |
| Friday, January 1, 2016 | 30390000000 | 216080000 |
| Sunday, January 1, 2017 | 26107000000 | 241203000 |
| Monday, January 1, 2018 | 22127000000 | 214109000 |
| Tuesday, January 1, 2019 | 22449000000 | 204890000 |
| Wednesday, January 1, 2020 | 24689000000 | 227976000 |
| Friday, January 1, 2021 | 27305000000 | 356128000 |
| Saturday, January 1, 2022 | 27281000000 | 426409000 |
| Sunday, January 1, 2023 | 27116000000 | 837999000 |
| Monday, January 1, 2024 | 28754000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of the pharmaceutical industry, Gilead Sciences, Inc. and HUTCHMED (China) Limited have been vying for dominance in annual revenue. From 2014 to 2023, Gilead Sciences consistently outperformed HUTCHMED, with revenues peaking in 2015 at approximately $32.6 billion. In contrast, HUTCHMED's revenue, while growing, reached its highest in 2023 at around $838 million, marking a significant increase of over 800% from 2014. This stark contrast highlights Gilead's established market presence and HUTCHMED's emerging growth trajectory. Despite the disparity, HUTCHMED's revenue growth rate is noteworthy, suggesting potential for future competition. As the pharmaceutical sector evolves, these trends offer insights into the strategic maneuvers of both companies, with Gilead maintaining a stronghold and HUTCHMED steadily climbing the ranks.
Revenue Insights: Eli Lilly and Company and HUTCHMED (China) Limited Performance Compared
Revenue Insights: Gilead Sciences, Inc. and Alnylam Pharmaceuticals, Inc. Performance Compared
Revenue Insights: Gilead Sciences, Inc. and BeiGene, Ltd. Performance Compared
Revenue Showdown: Gilead Sciences, Inc. vs Incyte Corporation
Gilead Sciences, Inc. vs Lantheus Holdings, Inc.: Annual Revenue Growth Compared
Who Generates More Revenue? Gilead Sciences, Inc. or MorphoSys AG
Who Generates More Revenue? Gilead Sciences, Inc. or Bausch Health Companies Inc.
Who Generates More Revenue? Gilead Sciences, Inc. or ImmunityBio, Inc.
Annual Revenue Comparison: BioMarin Pharmaceutical Inc. vs HUTCHMED (China) Limited
Breaking Down Revenue Trends: Walgreens Boots Alliance, Inc. vs HUTCHMED (China) Limited
Annual Revenue Comparison: Pharming Group N.V. vs HUTCHMED (China) Limited
Who Generates More Revenue? HUTCHMED (China) Limited or Travere Therapeutics, Inc.